Fingerprint
Dive into the research topics of 'Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk
Luisa Sophie Schneider, Silka Dawn Freiesleben, Gerard van Breukelen, Xiao Wang, Frederic Brosseron, Michael T. Heneka, Stefan Teipel, Luca Kleineidam, Melina Stark, Nina Roy-Kluth, Michael Wagner, Annika Spottke, Matthias Schmid, Sandra Roeske, Christoph Laske, Matthias H. Munk, Robert Perneczky, Boris Stephan Rauchmann, Katharina Buerger, Daniel Janowitz
- Charité – Universitätsmedizin Berlin
- Experimental and Clinical Research Center (ECRC)
- German Center for Neurodegenerative Diseases (DZNE)
- University of Maastricht
- University of Luxembourg
- Rostock University Medical Center
- University of Bonn and University Hospital Bonn
- University of Bonn
- University Clinic Tuebingen
- Universitätsklinikum Tübingen
- Ludwig-Maximilians-Universität München
- Imperial College London
- Munich Cluster for Systems Neurology (SyNergy)
- University of Sheffield
- Otto-von-Guericke University
- University of Cologne
- University of Cologne
- University of Aveiro
- University Medical Center
- The University of Edinburgh Medical School
Research output: Contribution to journal › Article › peer-review